NCT07217600View on ClinicalTrials.gov

Ondansetron Orodispersible Film for Vomiting Prevention in Pediatric Radiotherapy

PHASE4RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 25, 2025

Primary Completion Date

March 31, 2026

Study Completion Date

April 30, 2026

Conditions
Radiotherapy-induced Nausea and Vomiting (RINV)Pediatric Cancer
Interventions
DRUG

Ondansetron orodispersible film once

Take ondansetron orodispersible film once 1-2 hours before each radiotherapy

DRUG

Ondansetron orodispersible film twice

Take ondansetron orodispersible film once before each radiotherapy , and once again 8 hours after the first dose.

Trial Locations (1)

Unknown

RECRUITING

Chongqing University Cancer Hospital, Chongqing

All Listed Sponsors
lead

Chongqing University Cancer Hospital

OTHER